Risk stratification of the normal perfusion scan: Does normal stress perfusion always mean very low risk?

Journal of Nuclear Cardiology

Volumn 10, Issue 1, 2003, Pages 87-91

  Dahlberg, Seth ^a   Leppo, Jeffrey ^a  

^a UMASS MEMORIAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA; CORONARY VASODILATING AGENT; FLUORODEOXYGLUCOSE F 18; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; NITROGEN 13; TETROFOSMIN TC 99M; THALLIUM 201;

ANGIOCARDIOGRAPHY; CORONARY ARTERY COLLATERAL CIRCULATION; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; EDITORIAL; ELECTROCARDIOGRAPHY; EXERCISE TEST; HEART DEATH; HEART INFARCTION; HEART MUSCLE BLOOD FLOW; HEART MUSCLE PERFUSION; HUMAN; IMAGE ANALYSIS; IMAGING SYSTEM; ISCHEMIC HEART DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0037228214     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1067/mnc.2003.6     Document Type: Editorial

References (54)

1. Gould KL, Hamilton GW, Lipscomb K, Ritchie JL, Kennedy JW. A method for assessing stress induced regional malperfusion during coronary arteriography: experimental validation and clinical application. Am J Cardiol 1974;34:557-64.
2. Gould KL. Noninvasive assessment of coronary stenoses by myocardial perfusion imaging during pharmacologic coronary vasodilation. I. Physiologic basis and experimental validation. Am J Cardiol 1978;41:267-78.
3. Okada RD. Leppo JA, Boucher CA, Pohost GM. Myocardial kinetics of thallium-201 after dipyridamole infusion in normal canine myocardium and in myocardium distal to a stenosis. J Clin Invest 1982;69:199-209.
4. Leppo J, Boucher CA, Okada RD, et al. Serial thallium-201 myocardial imaging after dipyridamole infusion: diagnostic utility in detecting coronary stenoses and relationship to regional wall motion. Circulation 1982;66:649-57.
5. 99mTc-sestamibi myocardial perfusion imaging with poststenotic coronary flow reserve in patients with angiographically intermediate coronary artery stenoses. Circulation 1994;89:2150-60.
6. 201Tl imaging and coronary angiography. Circulation 1997;96:484-90.
7. Becker LC. Effect of nitroglycerin and dipyridamole on regional left ventricular blood flow during coronary artery occlusion. J Clin Invest 1976;58:1287-96.
8. Becker LC. Conditions for vasodilator-induced coronary steal in experimental myocardial ischemia. Circulation 1978;57:1103-10.
9. Leppo JA, Simons M, Hood WB Jr. Effect of adenosine on transmural flow gradients in normal canine myocardium. J Cardiovasc Pharmacol 1984;6:1115-9.
10. Nishimura S, Kimball KT, Mahmarian JJ, Verani MS. Angiographic and hemodynamic determinants of myocardial ischemia during adenosine thallium-201 scintigraphy in coronary artery disease. Circulation 1993;87:1211-9.
11. Demer LL, Gould KL, Goldstein RA, Kirkeeide RL. Noninvasive assessment of coronary collaterals in man by PET perfusion imaging. J Nucl Med 1990;31:259-70.
12. Akinboboye OO, Idris O, Chou RL, et al. Absolute quantitation of coronary steal induced by intravenous dipyridamole. J Am Coll Cardiol 2001;37:109-16.
13. Araujo LI, McFalls EO, Lammertsma AA, Jones T, Maseri A. Dipyridamole-induced increased glucose uptake in patients with single-vessel coronary artery disease assessed with PET. J Nucl Cardiol 2001;8:339-46.
14. Seiler C, Fleisch M, Meier B. Direct intracoronary evidence of collateral steal in humans. Circulation 1997;96:4261-7.
15. Schulman SP, Achuff SC, Griffith LSC, et al. Prognostic cardiac catheterization variables in survivors of acute myocardial infarction: a five year prospective study. J Am Coll Cardiol 1988;11:1164-72.
16. Peduzzi P, Hultgren H, Thomsen J, Detre K. Ten-year effect of medical and surgical therapy on quality of life: Veterans Administration Cooperative Study of Coronary Artery Surgery. Am J Cardiol 1987;59:1017-23.
17. Davis KB, Chaitman B, Ryan T, Bittner V, Kennedy JW. Comparison of 15-year survival for men and women after initial medical or surgical treatment for coronary artery disease: a CASS Registry study. J Am Coll Cardiol 1995;25:1000-9.
18. Varnauskas E, European Coronary Surgery Study Group. Twelve-year follow-up of survival in the randomized European Coronary Surgery study. N Engl J Med 1988;319:332-7.
19. Leppo JA, O'Brien J, Rothendler JA, Getchell JD, Lee VW. Dipyridamole-thallium-201 scintigraphy in the prediction of future cardiac events after acute myocardial infarction. N Engl J Med 1984;310:1014-8.
20. Leppo J, Plaja J, Gionet M, et al. Noninvasive evaluation of cardiac risk before elective vascular surgery. J Am Coll Cardiol 1987;9:269-76.
21. Lette J, Waters D, Lapointe J, et al. Usefulness of the severity and extent of reversible perfusion defects during thallium-dipyridamole imaging for cardiac risk assessment before noncardiac surgery. Am J Cardiol 1989;64:276-81.
22. Eagle KA, Coley CM, Newell JB, et al. Combining clinical and thallium data optimizes preoperative assessment of cardiac risk before major vascular surgery. Ann Intern Med 1989;110:859-66.
23. Eagle KA, Berger PB, Calkins H, et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery - executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). J Am Coll Cardiol 2002;39:542-53.
24. Brown KA. Prognostic value of myocardial perfusion imaging: state of the art and new developments. J Nucl Cardiol 1996;3:516-37.
25. Zaret BL, Wackers FJ. Nuclear cardiology (second of two parts). N Engl J Med 1993;329:855-63.
26. Zaret BL, Wackers FJ. Nuclear cardiology (first of two parts). N Engl J Med 1993;329:775-83.
27. Kozma C, Macklin W, Cummins LM, Mauer R. Anatomy, physiology, and biochemistry of the rabbit. In: Weisbroth SH, Flatt RE, Kraus AL, editors. The biology of the laboratory rabbit. New York: Academic Press; 1974. p. 50-70.
28. Gibbons RJ, Hodge DO, Berman DS, et al. Long-term outcome of patients with intermediate-risk exercise electrocardiograms who do not have myocardial perfusion defects on radionuclide imaging. Circulation 1999;100:2140-5.
29. Zafrir N, Dahlberg ST, Villegas BJ, Leppo JA. Prognostic utility of increased pulmonary thallium uptake in patients without ischemia. J Nucl Cardiol 1996;3:301-7.
30. Brown KA, Rown M. Prognostic value of a normal exercise myocardial perfusion imaging study in patients with angiographically significant coronary artery disease. Am J Cardiol 1993;71:865-7.
31. Fattah AA, Kamal AM, Pancholy S, et al. Prognostic implications of normal exercise tomographic thallium images in patients with angiographic evidence of significant coronary artery disease. Am J Cardiol 1994;74:769-71.
32. Platia EV, Griffith LSC, Watkins L Jr, et al. Treatment of malignant ventricular arrhythmias with endocardial resection and implantation of the automatic cardioverter-defibrillator. N Engl J Med 1986;314:213-6.
33. Froelicher VF, Perdue S, Pewen W, Risch M. Application of meta-analysis using an electronic spread sheet to exercise testing in patients after myocardial infarction. Am J Med 1987;83:1045-54.
34. Villella A, Maggioni AP, Villella M, et al. Prognostic significance of maximal exercise testing after myocardial infarction treated with thrombolytic agents: the GISSI-2 data-base. Lancet 1995;346:523-9.
35. Hachamovitch R, Berman DS, Shaw LJ, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction. Circulation 1998;97:535-43.
36. Hachamovitch R, Berman DS, Kiat H, et al. Incremental prognostic value of adenosine stress myocardial perfusion single-photon emission computed tomography and impact on subsequent management in patients with or suspected of having myocardial ischemia. Am J Cardiol 1997;80:426-33.
37. Heller GV, Herman SD, Travin MI, et al. Independent prognostic value of intravenous dipyridamole with technetium-99m sestamibi tomographic imaging in predicting cardiac events and cardiac-related hospital admissions. J Am Coll Cardiol 1995;26:1202-8.
38. Stratmann HG, Tamesis BR, Younis LT, Wittry MD, Miller DD. Prognostic value of dipyridamole technetium-99m sestamibi myocardial tomography in patients with stable chest pain who are unable to exercise. Am J Cardiol 1994;73:647-52.
39. Lette J, Bertrand C, Gossard D, et al. Long-term risk stratification with dipyridamole imaging. Am Heart J 1995;129:880-6.
40. Abbott BG, Afshar M, Berger AK, Wackers FJTh. Prognostic significance of ischemic electrocardiographic changes during adenosine infusion in patients with normal myocardial perfusion imaging. J Nucl Cardiol 2002;9.
41. Klodas EM, Miller TD, Christian TF, Hodge DO, Gibbons RJ. Prognostic significance of ischemic electrocardiographic changes during vasodilator stress testing in patients with normal SPECT images. J Nucl Cardiol 2003;10.
42. 99mTc-sestamibi single-photon emission computed tomography. Circulation 1996;93:463-73.
43. Christian TF, Miller TD, Bailey KR, Gibbons RJ. Noninvasive identification of severe coronary artery disease using exercise tomographic thallium-201 imaging. Am J Cardiol 1992;70:14-20.
44. Mahmarian JJ, Boyce TM, Goldberg RK, et al. Quantitative exercise thallium-201 single photon emission computed tomography for the enhanced diagnosis of ischemic heart disease. J Am Coll Cardiol 1990;15:318-29.
45. Tamaki N, Yonekura Y, Mukai T, et al. Segmental analysis of stress thallium myocardial emission tomography for localization of coronary artery disease. Eur J Nucl Med 1984;9:99-105.
46. Hendel RC, Berman DS, Cullom SJ, et al. Multicenter clinical trial to evaluate the efficacy of correction for photon attenuation and scatter in SPECT myocardial perfusion imaging. Circulation 1999;99:2742-9.
47. Sambuceti G, Parodi O, Marcassa C, et al. Alteration in regulation of myocardial blood flow in one-vessel coronary artery disease determined by positron emission tomography. Am J Cardiol 1993;72:538-43.
48. Uren NG, Marraccini P, Gistri R, De Silva R, Camici PG. Altered coronary vasodilator reserve and metabolism in myocardium subtended by normal arteries in patients with coronary artery disease. J Am Coll Cardiol 1993;22:650-8.
49. Uren NG, Crake T, Lefroy DC, et al. Reduced coronary vasodilator function in infarcted and normal myocardium after myocardial infarction. N Engl J Med 1994;331:222-7.
50. Emlein G, Villegas B, Dahlberg S, Leppo J. Left ventricular cavity size determined by preoperative dipyridamole thallium scintigraphy as a predictor of late cardiac events in vascular surgery patients. Am Heart J 1996;131:907-14.
51. 201Tl single-photon emission computed tomography. Circulation 1999;100:1964-70.
52. Jain D, Thompson B, Wackers FJTh, Zaret BL. Relevance of increased lung thallium uptake on stress imaging in patients with unstable angina and non-Q wave myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI)-IIIB study. J Am Coll Cardiol 1997;30:421-9.
53. Hachamovitch R, Berman DS, Kiat H, et al. Exercise myocardial perfusion SPECT in patients without known coronary artery disease: incremental prognostic value and use in risk stratification. Circulation 1996;93:905-14.
54. Calnon DA, McGrath PD, Doss AL, et al. Prognostic value of dobutamine stress technetium-99m-sestamibi single-photon emission computed tomography myocardial perfusion imaging: stratification of a high-risk population. J Am Coll Cardiol 2001;38:1511-7.